Our study explores a likely new gene‐phenotype relationship between a novel GABRB3 gene variant and the clinical manifestations of Dravet syndrome (DS). Here, GABRB3 is linked to encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.